Biokine: BioLineRx Announces Updated Phase 2a Data from a Combination Trial of BL-8040, KEYTRUDA® & Chemotherapy as 2nd-line therapy in Metastatic Pancreatic Cancer – CBI

Homepage / Press Release / Biokine: BioLineRx Announces Updated Phase 2a Data from a Combination Trial of BL-8040, KEYTRUDA® & Chemotherapy as 2nd-line therapy in Metastatic Pancreatic Cancer

Press Release

Biokine: BioLineRx Announces Updated Phase 2a Data from a Combination Trial of BL-8040, KEYTRUDA® & Chemotherapy as 2nd-line therapy in Metastatic Pancreatic Cancer